Northrop Grumman Secures Missile-Defense Contract Amid Valuation Concerns
On September 4, 2026, Northrop Grumman (NYSE:NOC) won a $508.5 million contract from the U.S. Missile Defense Agency to support ICBM and IRBM flight tests through 2035. This follows recent framework agreements totaling approximately $3 billion for expanding production of PAC-3 and THAAD interceptors, as well as additional missile-defense awards in 2025. Despite these contract wins, Northrop Grumman's stock has underperformed relative to peers like Lockheed Martin (LMT), trading at a forward P/E ratio of around 16 times earnings—significantly lower than the broader defense sector. The valuation discount is attributed to execution issues on major programs such as Sentinel ICBM and B-21 bomber, which led to cost overruns and financial charges. The company's long-term prospects remain tied to U.S. missile-defense modernization efforts like Golden Dome, but institutional investors are cautious due to margin pressures and program risks. With low short interest (1.7% of float) and a defensive beta (-0.11), the stock is seen as offering diversification at an entry discount.
Topics: government contracts missile defense valuation analysis